Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. 2004

Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
Viral Immunology Group, The Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire RG20 7NN, England, UK.

CD8+ cytotoxic T lymphocytes (CTLs) play an important role in containment of virus replication in primary human immunodeficiency virus (HIV) infection. HIV's ability to mutate to escape from CTL pressure is increasingly recognized; but comprehensive studies of escape from the CD8 T cell response in primary HIV infection are currently lacking. Here, we have fully characterized the primary CTL response to autologous virus Env, Gag, and Tat proteins in three patients, and investigated the extent, kinetics, and mechanisms of viral escape from epitope-specific components of the response. In all three individuals, we observed variation beginning within weeks of infection at epitope-containing sites in the viral quasispecies, which conferred escape by mechanisms including altered peptide presentation/recognition and altered antigen processing. The number of epitope-containing regions exhibiting evidence of early CTL escape ranged from 1 out of 21 in a subject who controlled viral replication effectively to 5 out of 7 in a subject who did not. Evaluation of the extent and kinetics of HIV-1 escape from >40 different epitope-specific CD8 T cell responses enabled analysis of factors determining escape and suggested that escape is restricted by costs to intrinsic viral fitness and by broad, codominant distribution of CTL-mediated pressure on viral replication.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002860 Chromium Radioisotopes Unstable isotopes of chromium that decay or disintegrate emitting radiation. Cr atoms with atomic weights of 46-49, 51, 55, and 56 are radioactive chromium isotopes. Radioisotopes, Chromium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015750 Genes, gag DNA sequences that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen. gag Genes,gag Gene,Gene, gag

Related Publications

Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
November 2007, Journal of virology,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
October 2005, Journal of virology,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
March 2001, Journal of virology,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
September 2005, Journal of virology,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
September 1994, Journal of virology,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
January 2000, Stem cells (Dayton, Ohio),
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
November 2010, PLoS computational biology,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
November 2005, Journal of virology,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
October 2001, Immunological reviews,
Nicola A Jones, and Xiping Wei, and Darren R Flower, and Mailee Wong, and Franziska Michor, and Michael S Saag, and Beatrice H Hahn, and Martin A Nowak, and George M Shaw, and Persephone Borrow
December 2003, Journal of virology,
Copied contents to your clipboard!